Persist AI and Nivagen to Collaborate on AI-Driven Manufacturing Process for Long-Acting Injectable
The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. Persist AI and Nivagen have announced a collaboration to co-develop a next-generation manufacturing process for long-acting injectable (LAI) drugs, using Persist’s AI-based formulation technology and Nivagen’s manufacturing capabilities. The collaboration aims…